329 related articles for article (PubMed ID: 16536426)
1. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
[TBL] [Abstract][Full Text] [Related]
2. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2005 Jun; 77(11):3579-85. PubMed ID: 15924392
[TBL] [Abstract][Full Text] [Related]
3. Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry.
Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
J Chromatogr A; 2011 Feb; 1218(8):1139-46. PubMed ID: 21256494
[TBL] [Abstract][Full Text] [Related]
4. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes.
Thomas A; Thevis M; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2007 Mar; 79(6):2518-24. PubMed ID: 17300174
[TBL] [Abstract][Full Text] [Related]
6. Doping control analysis of insulin and its analogues in equine plasma by liquid chromatography-tandem mass spectrometry.
Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
J Chromatogr A; 2008 Aug; 1201(2):183-90. PubMed ID: 18501368
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
Thevis M; Thomas A; Schänzer W
Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
[TBL] [Abstract][Full Text] [Related]
8. Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis.
Thevis M; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2005; 19(7):928-36. PubMed ID: 15747323
[TBL] [Abstract][Full Text] [Related]
9. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS.
Thomas A; Kohler M; Schänzer W; Delahaut P; Thevis M
Analyst; 2011 Mar; 136(5):1003-12. PubMed ID: 21157622
[TBL] [Abstract][Full Text] [Related]
10. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
11. Insulin.
Thevis M; Thomas A; Schänzer W
Handb Exp Pharmacol; 2010; (195):209-26. PubMed ID: 20020367
[TBL] [Abstract][Full Text] [Related]
12. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
Bredehöft M; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
[TBL] [Abstract][Full Text] [Related]
13. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
[TBL] [Abstract][Full Text] [Related]
14. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
Thomas A; Schänzer W; Delahaut P; Thevis M
Methods; 2012 Feb; 56(2):230-5. PubMed ID: 21871962
[TBL] [Abstract][Full Text] [Related]
15. Doping control analysis of selected peptide hormones using LC-MS(/MS).
Thevis M; Thomas A; Schänzer W
Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
17. Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
Thevis M; Wilkens F; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(22):3393-402. PubMed ID: 17051614
[TBL] [Abstract][Full Text] [Related]
18. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
Kolmonen M; Leinonen A; Pelander A; Ojanperä I
Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
[TBL] [Abstract][Full Text] [Related]
19. Detection of recombinant insulins in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns.
Mazzarino M; Senofonte M; Martinelli F; de la Torre X; Botrè F
Anal Bioanal Chem; 2019 Dec; 411(30):8153-8162. PubMed ID: 31797014
[TBL] [Abstract][Full Text] [Related]
20. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
